Peritoneal Dialysis Is an Option for Acute Kidney Injury Management in Patients with COVID-19.
Blood Purif
; 50(3): 283-289, 2021.
Article
in English
| MEDLINE | ID: covidwho-817873
ABSTRACT
In December 2019, cases of acute respiratory illness of unknown origin were reported in Wuhan, China. The disease is caused by "severe acute respiratory syndrome coronavirus 2". After identifying severe lung damage, injury to other organs, such as the kidney, has been identified. Peritoneal dialysis is a renal replacement therapy (RRT) and is at least as effective as other extracorporeal therapy options, with significant cost-effective advantages. However, this strategy is rarely used for the management of acute kidney injury in severe lung disease. In this review, we explore PD as an RRT strategy that may be a key instrument in countries and hospitals with limited access to all RRTs.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Peritoneal Dialysis
/
Acute Kidney Injury
/
Pandemics
/
SARS-CoV-2
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Blood Purif
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS